Solvex Edibles (544539)
CyclicalScore breakdown: P/E: 3/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹26 |
| Market Cap | ₹23.28 Cr |
| P/E Ratio | 5.92 |
| ROCE | 0% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | -16.84% |
| Debt/Equity | — |
| Sales Growth | -9.94% |
| Sector | Agricultural Food & other Products |
Strengths
- Trailing P/E of 5.92 implies a low valuation relative to delivered earnings.
- Latest quarter shows positive net profit of ₹1 crore on ₹42 crore sales, indicating the company is still profitable.
- Small market cap of ₹23 crore means even modest absolute earnings can affect valuation if fundamentals stabilise.
Concerns
- Sales declined 9.94% and profit declined 16.84%, showing a shrinking business.
- Piotroski F-Score of 2/9 signals poor financial health and likely operational deterioration.
- ROCE of 0.00% suggests the company is not generating an adequate return on capital employed.
- Missing promoter holding, debt/equity and book value data prevent a proper Graham-style balance sheet check.
AI Analysis
Let me start with what I can see. Solvex Edibles is a tiny ₹23 crore market cap edible oil player at ₹26 per share. The trailing P/E of 5.92 looks cheap, but cheapness alone is not a purchase ticket. The business is shrinking: sales down nearly 10% and profits down almost 17%. In the latest quarter, it earned ₹1 crore on ₹42 crore sales—a thin 2.4% margin. That tells me this is a low-margin commodity operation with little pricing power. The Piotroski score of 2 out of 9 is a serious red flag; it means the fundamentals are deteriorating, not healing. ROCE is reported as 0.00%, which is unacceptable for any business I would consider owning. I would not be comforted by the lack of dividend. Furthermore, critical data—book value, debt/equity, promoter holding—are missing. As Graham would say, you cannot analyze in a vacuum; without a balance sheet, I cannot estimate intrinsic value or margin of safety. This looks like a cyclical commodity business caught in an adverse part of the cycle. The low P/E may reflect an expected decline in earnings, not a bargain. If the edible oil industry turns, a low-cost operator could survive, but I have no evidence Solvex has a moat. I would not classify this as a stalwart or grower. It is a cyclical, at best, with deterioration. I need to see stabilization in quarterly profit, better capital returns, and honest disclosure before I would even put it on my watchlist. In investing, avoiding permanent loss is more important than finding temporary bargains. With F-score 2 and negative growth, this is a pass for me today.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer